Genehub Ltd

DataGardener
live
Micro

Genehub Ltd

14313535•Private Limited With Share Capital

3Rd Floor 86 - 90 Paul Street, London, EC2A4NE

Get Full Access

Visit WebsiteBook a Direct Call
Incorporated

23/08/2022

Company Age

3 years

Directors

1

Employees

5

SIC Code

63110

Risk

low risk

Company Overview

Registration, classification & business activity

Genehub Ltd (14313535) is a private limited with share capital incorporated on 23/08/2022 (3 years old) and registered in london, EC2A4NE. The company operates under SIC code 63110 and is classified as Micro.

Genehub is the first patient-controlled biobank to incentivise patients who share their anonymised dna data with researchers and clinicians. patients are rewarded with free dna tests and insights, which unlocks precision prescribing and faster access to drug trials. precision prescribing improves pa...

Private Limited With Share Capital
SIC: 63110
Micro
Incorporated 23/08/2022
EC2A4NE
5 employees

Financial Overview

Total Assets

£130.8K

Liabilities

£101.9K

Net Assets

£29.0K

Cash

£37.1K

Key Metrics

5

Employees

1

Directors

12

Shareholders

1

PSCs

Board of Directors

1
C
craig coulton
director

Filed Documents

34
Capital Cancellation Treasury Shares With Date Currency Capital Figure
Category:Capital
Date:29-12-2025
Capital Return Purchase Own Shares Treasury Capital Date
Category:Capital
Date:16-12-2025
Confirmation Statement With Updates
Category:Confirmation Statement
Date:01-12-2025
Change To A Person With Significant Control
Category:Persons With Significant Control
Date:29-11-2025
Change Person Director Company With Change Date
Category:Officers
Date:16-11-2025
Change Registered Office Address Company With Date Old Address New Address
Category:Address
Date:16-11-2025
Accounts With Accounts Type Total Exemption Full
Category:Accounts
Date:09-10-2025
Accounts Amended With Accounts Type Total Exemption Full
Category:Accounts
Date:04-09-2025
Capital Allotment Shares
Category:Capital
Date:11-06-2025
Cessation Of A Person With Significant Control
Category:Persons With Significant Control
Date:08-01-2025
Confirmation Statement With Updates
Category:Confirmation Statement
Date:20-11-2024
Resolution
Category:Resolution
Date:17-11-2024
Accounts With Accounts Type Total Exemption Full
Category:Accounts
Date:13-11-2024
Notification Of A Person With Significant Control
Category:Persons With Significant Control
Date:12-11-2024
Capital Allotment Shares
Category:Capital
Date:11-11-2024
Capital Allotment Shares
Category:Capital
Date:22-10-2024
Termination Director Company With Name Termination Date
Category:Officers
Date:15-10-2024
Confirmation Statement With Updates
Category:Confirmation Statement
Date:13-09-2024
Change Person Director Company With Change Date
Category:Officers
Date:22-08-2024
Change To A Person With Significant Control
Category:Persons With Significant Control
Date:22-08-2024
Cessation Of A Person With Significant Control
Category:Persons With Significant Control
Date:19-08-2024
Termination Director Company With Name Termination Date
Category:Officers
Date:19-08-2024
Appoint Person Director Company With Name Date
Category:Officers
Date:24-07-2024
Capital Allotment Shares
Category:Capital
Date:07-03-2024
Confirmation Statement With Updates
Category:Confirmation Statement
Date:26-08-2023
Change Person Director Company With Change Date
Category:Officers
Date:22-08-2023
Accounts With Accounts Type Micro Entity
Category:Accounts
Date:23-06-2023
Change Account Reference Date Company Previous Shortened
Category:Accounts
Date:07-06-2023
Resolution
Category:Resolution
Date:07-12-2022
Second Filing Capital Allotment Shares
Category:Capital
Date:01-12-2022
Capital Allotment Shares
Category:Capital
Date:30-11-2022
Capital Alter Shares Subdivision
Category:Capital
Date:20-10-2022
Resolution
Category:Resolution
Date:20-10-2022
Incorporation Company
Category:Incorporation
Date:23-08-2022

Innovate Grants

1

This company received a grant of £399610.0 for An Innovative Platform Allowing Patients To Consent To Data Reuse, Reducing Clinical Trial Recruitment Timeline By 50% And Saving Customers Up To £150M. The project started on 01/10/2023 and ended on 31/03/2025.

Risk Assessment

low risk

International Score

Future Factor

excellent

Performance Rating

Accounts

Typetotal exemption full
Due Date31/12/2026
Filing Date09/10/2025
Latest Accounts31/03/2025

Trading Addresses

32-38 Leman Street, London, E18EW
3Rd Floor 86 - 90 Paul Street, London, EC2A4NERegistered

Related Companies

1
bloom teas limited
live

Contact

3Rd Floor 86 - 90 Paul Street, London, EC2A4NE